PARATHYROID HORMONE RECEPTOR MEDIATES THE ANTI-MYELOMA EFFECT OF PROTEASOME INHIBITORS

Clinically significant serum parathyroid hormone (PTH) variations have been reported in multiple myeloma (MM) patients treated with proteasome inhibitors. To elucidate the association between serum PTH variations and proteasome inhibition in MM, the effect of PTH and PTHR1 ligands on the proteasome...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zangari, Maurizio, Berno, Tamara, Yang, Ye, Zeng, Ming, Xu, Hongwei, Pappas, Lisa, Tricot, Guido, Kamalakar, Archana, Yoon, Donghoon, Suva, Larry J.
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3967551/
https://ncbi.nlm.nih.gov/pubmed/24389365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2013.12.025
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires